Key statistics
As of last trade, Elicio Therapeutics Inc (ELTX:NMQ) traded at 5.00, 68.92% above the 52 week low of 2.96 set on Feb 07, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 5.24 |
---|---|
High | 5.24 |
Low | 5.00 |
Bid | 5.00 |
Offer | 5.20 |
Previous close | 5.09 |
Average volume | 17.33k |
---|---|
Shares outstanding | 10.77m |
Free float | 7.74m |
P/E (TTM) | -- |
Market cap | 54.84m USD |
EPS (TTM) | -4.83 USD |
Data delayed at least 15 minutes, as of Sep 19 2024 16:12 BST.
More ▼
- Elicio Therapeutics Reports Inducement Grants
- Elicio Therapeutics Announces Three Upcoming Presentations Focused on its Lymph Node Targeted, mKRAS-Specific Amphiphile Vaccines
- Elicio Therapeutics to Present at the H.C. Wainwright 26th Annual Global Investment Conference
- Elicio Therapeutics Reports Second Quarter 2024 Financial Results and Provides Corporate Updates
- Elicio Therapeutics Announces Closing of Private Placement of $20.0 Million Convertible Note
- Elicio Therapeutics Announces Pricing of $11.5 Million Underwritten Public Offering
- Elicio Therapeutics Announces Proposed Public Offering
- Elicio Therapeutics Announces Preliminary Disease-Free Survival analysis from the Ongoing AMPLIFY-7P Phase 1a Study of ELI-002 7P
- Elicio Therapeutics to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference
- Elicio Therapeutics Announces Publication of Preclinical Data Demonstrating TCR-T Cell Therapy in Combination with Lymph Node-Targeted Amphiphile-Immunotherapy Enhanced Anti-Tumor Function and Eradicated Solid Tumors
More ▼